This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sunstar Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Hirohisa Suidou: Innovator in Peptide Research
Introduction
Hirohisa Suidou is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of peptide research, particularly in the development of novel compounds with therapeutic potential. His work focuses on innovations that can impact health and medicine.
Latest Patents
Hirohisa Suidou holds a patent for "Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof." This patent describes a novel peptide with ACE inhibitory activity, specifically a tripeptide consisting of Leu-Arg-Ala. This innovation has potential applications in treating conditions related to hypertension and cardiovascular health.
Career Highlights
Suidou's career is marked by his dedication to research and development in the field of biochemistry. His work has led to advancements in understanding how specific peptides can influence biological processes. His innovative approach has garnered attention in both academic and industrial circles.
Collaborations
Hirohisa Suidou has collaborated with notable colleagues, including Kousaku Ohinata and Yuutarou Ogawa. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.
Conclusion
Hirohisa Suidou's contributions to peptide research exemplify the impact of innovation in the field of health and medicine. His work continues to pave the way for new therapeutic possibilities.